Hedge fund still a big buyer of Healthways

North Tide takes stake past 12%
Nov 13, 2015 7:16 AM

Analysts trim Healthways targets

Barrington Research analyst Michael Petusky has trimmed his price target for shares of Healthways to $13 from $18 following the population health services company’s quarterly report and the unveiling of a wide-ranging restructuring plan. Petusky still has Healthways at ‘outperform.’

Over at Barclays, Josh Raskin is still a little more guarded at ‘underweight.’ He also has cut his target for Healthways shares (Ticker: HWAY), which closed Tuesday at $11.48, to $12 from $15.

Nov 4, 2015 7:20 AM

Healthways to restructure, execs coming and going

Company streamlining divisions and selling subsidiary, expects $40M in write-downs
Oct 30, 2015 6:51 AM

Healthways, Hawaiian health insurer restructure, extend deal

8% of local company's employees will transfer to client's payroll
Sep 15, 2015 2:25 PM

Former Healthways COO wants $3M+ over firing

Michela says he was served papers after saying he wouldn't wait in line behind CEO-to-be Tramuto
Aug 25, 2015 7:03 AM

Healthways sends COO packing

Exec on second stint with company was named to post year ago
Aug 20, 2015 7:54 AM

Healthways stays close to home for new CEO

Chairman preps move into corner office, is in line for $1.25M cash award
Aug 7, 2015 7:27 AM

Hedge fund declares big Healthways stake

Firm becomes seventh owner of at least 5%
Jul 30, 2015 11:48 AM

Earnings wrap: Healthways, Sitel

Population health management company surprises with profit; currency swings limit call center owner gains
Jul 24, 2015 6:48 AM

Analyst action: Healthways, Acadia

Two longtime Healthways analysts on Friday cut their price targets for the population health management play after new and interim CEO Alfred Lumsdaine said 2015 profits will not meet expectations. But both Brooks O'Neil at Dougherty and Sean Wieland at Piper Jaffray are not telling investors to stop buying the company's shares, keeping Healthways at 'buy' and 'overweight' ratings, respectively. O'Neil's target for Healthways, which on Friday fell 20 percent to $12.40 (Ticker: HWAY), has come all the way down to $15 from $25. Wieland is staying more upbeat: His target now stands at $25.50, down from $27.

The skies are decidedly brighter for shareholders of Acadia Healthcare, which has climbed about 25 percent so far in 2015 after rising by about a third last year. Mizuho Securities analysts see even better days ahead and have launched coverage of the Franklin-based company with an 'outperform' rating at a price target of $84. Acadia (Ticker: ACHC) closed Friday trading at $76.47.

Jun 22, 2015 7:19 AM